Skip to main content
HR 298 114th Congress House

Medical Testing Availability Act of 2015

Official title: To amend chapter V of the Federal Food, Drug, and Cosmetic Act to permit the sale of, and access to, "research use only" products.

Introduced: January 13, 2015 See on congress.gov
Health
Sign in to write a letter Sign in to watch
This bill died when the 114th Congress ended
It never became law before the 114th Congress (2015–2016) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jan 16, 2015
Referred to the Subcommittee on Health.
Jan 13, 2015
Introduced in House
Jan 13, 2015
Referred to the House Committee on Energy and Commerce.
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Latest action January 16, 2015

Referred to the Subcommittee on Health.

 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 2
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 298: Medical Testing Availability Act of 2015. 114th Congress. Open America. https://openamerica.io/bill/114-HR-298/
MLA
"H.R. 298: Medical Testing Availability Act of 2015." 114th Congress, 2026, Open America, https://openamerica.io/bill/114-HR-298/.
Bluebook (legal)
H.R. 298, 114th Cong. (2026), https://openamerica.io/bill/114-HR-298/.
Markdown link
[H.R. 298: Medical Testing Availability Act of 2015](https://openamerica.io/bill/114-HR-298/)
Report a problem